Sources and properties of triglyceride-rich lipoproteins containing apoB-48 and apoB-100 in postprandial blood plasma of patients with primary combined hyperlipidemia

Journal of Lipid Research

Volumn 43, Issue 7, 2002, Pages 1026-1034

  Kovar, J ^a,b   Havel, R J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Apolipoprotein B editing; Immunoaffinity chromatography; Retinol; Retinyl esters

Indexed keywords

APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; APOLIPOPROTEIN C; APOLIPOPROTEIN E; LIPOPROTEIN; MESSENGER RNA; RETINOL; RETINOL ESTER; TRIACYLGLYCEROL;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FAT INTAKE; FEMALE; HUMAN; HYPERLIPIDEMIA; IMMUNOAFFINITY CHROMATOGRAPHY; INTESTINE SECRETION; LIPOPROTEIN SECRETION; MALE; PATHOGENESIS; PLASMA; POSTPRANDIAL STATE; PRIORITY JOURNAL; SURFACE PROPERTY;

EID: 0036314388     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M100435-JLR200     Document Type: Article

References (41)

1. Postprandial hyperlipidemia and remnant lipoproteins
2. Disorders of the biogenesis and secretion of lipoproteins containing the B-apolipoproteins
3. Apolipoprotein B messenger RNA editing is developmentally regulated and widely expressed in human tissues
4. Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation
5. Apolipoprotein B-48 is the product of a messenger RNA with an organ- specific in-frame stop codon
6. Both apolipoproteins B-48 and B-100 are synthesized and secreted by the human intestine
7. Effect of fat feeding on human intestinal apolipoprotein B mRNA levels and editing
8. Epitopes of apolipoprotein B-100 and B-48 in both liver and intestine. Expression and evidence for local synthesis in recessive abetalipoproteinemia
9. Apolipoprotein B-100: Immunolocalization and synthesis in human intestinal mucosa
10. Presence of apolipoprotein B-100 in human intestine epithelial cells
11. Introduction: Structure and metabolism of plasma lipoproteins
12. Early effects of fat ingestion on lipids and lipoproteins of serum in man
13. Separation and determitiation of remnant-like particles in human serum using monoclonal antibodies to apo B-100 and apo A-I
14. Use of bacterial expression cloning to localize the epitopes for a series of monoclonal antibodies against apolipoprotein B100
15. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum
16. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol
17. Quantitative determination of serum triglycerides by the use of enzymes
18. Enzymatic determination of total serum cholesterol
19. The phospholipids of blood
20. Protein measurement with the Folin phenol reagent
21. Protocol for the study of the metabolism of retinyl esters in plasma lipoproteins during postprandial lipemia
22. Simultaneous quantification of apolipoproteins B-100, B-48, and E separated by SDSPAGE
23. Characterization of subfractions of triglyceride-rich lipoproteins separated by gel chromatography from blood plasma of normolipemic and hyperlipemic humans
24. Composition of proteins of mesenteric lymph chylomicrons in the rat and alterations produced upon exposure of chylomicrons to blood serum and serum proteins
25. In vitro transfer of chylormicron retinol and retinyl esters
26. Plasma clearance of chylomicrons labeled with retinyl palmitate in healthy human subjects
27. Effects of dietary cholesterol and fat saturation on plasma lipoproteins in an ethnically diverse population of healthy young men
28. Properties of triglyceride-rich and cholesterol-rich lipoproteins in the remnant-like particle (RLP) fraction of human blood plasma
29. Plasma lipoprotein retinoids after vitamin A feeding in normal man: Minimal appearance of retinyl esters among low-density lipoproteins
30. Chylomicron-retinyl palmitate clearance in type I hyperlipidemic families
31. Postprandial plasma vitamin A metabolism in humans: A reassessment of the use of plasma retinyl esters as markers for intestinally derived chylomicrons and their remnants
32. Contribution of apoB-48 and apoB-100 triglyceride-rich lipoproteins (TRL) to postprandial increases in the plasma concentration of TRL triglycerides and retinyl esters
33. Quantification of postprandial triglyceride-rich lipoproteins in healthy men by retinyl ester labeling and simultaneous measurement of apolipoproteins B-48 and B-100
34. Isolation and characterization of apolipoprotein B-48 and B-100 very low density lipoproteins from type III hyperlipoproteinemic subjects
35. Apolipoprotein B-48 and B-100 very low density lipoproteins. Comparison in dysbetalipoproteinemia (type III) and familial hypertriglyceridemia (type IV)
36. Differences in apolipoprotein and lipid composition between human chylomicron remnants and very low density lipoproteins isolated from fasting and postprandial plasma
37. Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in normal and lipoprotein lipase-deficient humans
38. Isolation and characterization of two distinct species of human very low density lipoproteins lacking apolipoprotein E
39. Effects of estrogenic oral contraceptives on the lipoprotein B particle system defined by apolipoproteins E and C-III content
40. McCollum Award Lecture, 1993: Triglyceriderich lipoproteins and atherlsclerosis-new perspectives